According to Actinium Pharmaceuticals's latest financial reports the company has $43.85 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $66.48 M | -9.61% |
2021-12-31 | $73.54 M | 19.94% |
2020-12-31 | $61.31 M | 986.45% |
2019-12-31 | $5.64 M | -35.96% |
2018-12-31 | $8.81 M | -35.54% |
2017-12-31 | $13.67 M | -24.08% |
2016-12-31 | $18 M | -18.05% |
2015-12-31 | $21.97 M | -1242.98% |
2014-12-31 | $-1.93 M | 23.28% |
2013-12-31 | $-1.56 M | -236.13% |
2012-12-31 | $1.14 M | 15.49% |
2011-12-31 | $0.99 M | -1148.44% |
2010-12-31 | $-0.1 M | -1.74% |
2009-12-31 | $-0.1 M | 30.19% |
2008-12-31 | $-0.08 M | 73.14% |
2007-12-31 | $-0.05 M | 132.11% |
2006-12-31 | $-0.02 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Genocea Biosciences
GNCA | $12.38 M | -71.76% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | $0.16 B | 265.22% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $5.07 B | 11,469.01% | ๐บ๐ธ USA |